Andrei Shustov - Feb 15, 2023 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Senior Vice President, Medical
Signature
/s/ Christina Blakley, Attorney in-fact for Andrei Shustov
Stock symbol
CLRB
Transactions as of
Feb 15, 2023
Transactions value $
$0
Form type
4
Date filed
3/16/2023, 06:02 PM
Next filing
Dec 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +100K $0.00 100K Feb 15, 2023 Common Stock 100K $1.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in three approximately equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continuous employment by the Issuer on each vesting date.